These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10954902)

  • 1. Intravesical and intravenous therapy of human bladder cancer by the herpes vector G207.
    Oyama M; Ohigashi T; Hoshi M; Nakashima J; Tachibana M; Murai M; Uyemura K; Yazaki T
    Hum Gene Ther; 2000 Aug; 11(12):1683-93. PubMed ID: 10954902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ cancer vaccination with a replication-conditional HSV for the treatment of liver metastasis of colon cancer.
    Endo T; Toda M; Watanabe M; Iizuka Y; Kubota T; Kitajima M; Kawakami Y
    Cancer Gene Ther; 2002 Feb; 9(2):142-8. PubMed ID: 11857031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
    Todo T; Martuza RL; Dallman MJ; Rabkin SD
    Cancer Res; 2001 Jan; 61(1):153-61. PubMed ID: 11196154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity.
    Toda M; Rabkin SD; Kojima H; Martuza RL
    Hum Gene Ther; 1999 Feb; 10(3):385-93. PubMed ID: 10048391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.
    Mineta T; Rabkin SD; Yazaki T; Hunter WD; Martuza RL
    Nat Med; 1995 Sep; 1(9):938-43. PubMed ID: 7585221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207.
    Walker JR; McGeagh KG; Sundaresan P; Jorgensen TJ; Rabkin SD; Martuza RL
    Hum Gene Ther; 1999 Sep; 10(13):2237-43. PubMed ID: 10498254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic viral therapy for human prostate cancer by conditionally replicating herpes simplex virus 1 vector G207.
    Oyama M; Ohigashi T; Hoshi M; Murai M; Uyemura K; Yazaki T
    Jpn J Cancer Res; 2000 Dec; 91(12):1339-44. PubMed ID: 11123435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic efficacy of G207, a conditionally replicating herpes simplex virus type 1 mutant, for gallbladder carcinoma in immunocompetent hamsters.
    Nakano K; Todo T; Chijiiwa K; Tanaka M
    Mol Ther; 2001 Apr; 3(4):431-7. PubMed ID: 11319903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of human renal cell carcinoma by a conditionally replicating herpes vector G207.
    Oyama M; Ohigashi T; Hoshi M; Murai M; Uyemura K; Yazaki T
    J Urol; 2001 Apr; 165(4):1274-8. PubMed ID: 11257700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1.
    Toda M; Rabkin SD; Martuza RL
    Hum Gene Ther; 1998 Oct; 9(15):2177-85. PubMed ID: 9794202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapy.
    Todo T; Rabkin SD; Chahlavi A; Martuza RL
    Hum Gene Ther; 1999 Nov; 10(17):2869-78. PubMed ID: 10584932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced efficacy of conditionally replicating herpes simplex virus (G207) combined with 5-fluorouracil and surgical resection in peritoneal cancer dissemination models.
    Nakano K; Todo T; Zhao G; Yamaguchi K; Kuroki S; Cohen JB; Glorioso JC; Tanaka M
    J Gene Med; 2005 May; 7(5):638-48. PubMed ID: 15754306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma.
    Chahlavi A; Todo T; Martuza RL; Rabkin SD
    Neoplasia; 1999 Jun; 1(2):162-9. PubMed ID: 10933051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer.
    Hadaschik BA; Zhang K; So AI; Fazli L; Jia W; Bell JC; Gleave ME; Rennie PS
    Cancer Res; 2008 Jun; 68(12):4506-10. PubMed ID: 18559493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
    Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV.
    Toda M; Iizuka Y; Kawase T; Uyemura K; Kawakami Y
    Cancer Gene Ther; 2002 Apr; 9(4):356-64. PubMed ID: 11960286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model.
    Cozzi PJ; Malhotra S; McAuliffe P; Kooby DA; Federoff HJ; Huryk B; Johnson P; Scardino PT; Heston WD; Fong Y
    FASEB J; 2001 May; 15(7):1306-8. PubMed ID: 11344122
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of the transcriptional regulatory sequences of human calponin promoter and their use in targeting a conditionally replicating herpes vector to malignant human soft tissue and bone tumors.
    Yamamura H; Hashio M; Noguchi M; Sugenoya Y; Osakada M; Hirano N; Sasaki Y; Yoden T; Awata N; Araki N; Tatsuta M; Miyatake SI; Takahashi K
    Cancer Res; 2001 May; 61(10):3969-77. PubMed ID: 11358814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of antitumor immune responses by multiple intratumoral inoculations of replication-conditional HSV and interleukin-12.
    Iizuka Y; Suzuki A; Kawakami Y; Toda M
    J Immunother; 2004; 27(2):92-8. PubMed ID: 14770080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of G207 in a novel peripheral nerve sheath tumor model.
    Mashour GA; Moulding HD; Chahlavi A; Khan GA; Rabkin SD; Martuza RL; Driever PH; Kurtz A
    Exp Neurol; 2001 May; 169(1):64-71. PubMed ID: 11312559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.